In this context, Stewart et al. analyzed FSCN1 expression by IHC in in situ and invasive adenocarcinoma of the endocervix and found FSCN1 overexpression to occur during the development and progression of some endocervical neoplasms, indicating the role of FSCN1 in tumor invasion [144]. The gene discussed is FSCN1; the disease is neoplasm.